Spero Therapeutics (SPRO) Q4 2022 Earnings

30MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-1.01
-0.49
0.03
0.55

Details

Expected EPS
0.04
Actual EPS
0.55
Surprise EPS
0.51
Surprise Percent
+1,275%

Description

Spero Therapeutics (SPRO) has reported earnings of 0.55 per share for Q4 2022.

0 Comments

Share your thoughts